Siegfried Holding AG (SWX:SFZN)

Market Cap	4.35B
Revenue (ttm)	1.29B
Net Income (ttm)	160.06M
Shares Out	4.37M
EPS (ttm)	36.88
PE Ratio	27.01
Forward PE	24.92
Dividend	3.80 (0.39%)
Ex-Dividend Date	May 3, 2024

Volume	18,304
Average Volume	11,544
Open	977.00
Previous Close	984.00
Day's Range	983.00 - 1,008.00
52-Week Range	843.00 - 1,188.00
Beta	0.71
RSI	42.50
Earnings Date	Feb 18, 2025

About Siegfried Holding AG

Siegfried Holding AG, together with its subsidiaries, provides contract development and manufacturing of active pharmaceutical ingredients (API) and finished dosage forms to the pharmaceutical industry worldwide. It offers pharmaceutical and analytical development, process and analytical transfer, commercial manufacturing and packaging, and scale-up and clinical trial material production services. The company develops and produces APIs and intermediates, as well as finished dosage forms, including solid oral dosage forms, sterile and aseptic fi...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1873
• Employees: 4,070
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: SFZN

Financial Performance

In 2024, Siegfried Holding AG's revenue was 1.29 billion, an increase of 1.82% compared to the previous year's 1.27 billion. Earnings were 160.06 million, an increase of 41.93%.